Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, The Panic-Proof Portfolio (Stockchase Research) and The Weekly Buzzing Stocks by Billy Kawasaki commented about whether INTU, RKLB, NVDA, DBB, PDBC, COPX are stocks to buy or sell.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate COPX as a TOP PICK.  With inflation, global energy infrastructure and even AI data center interest copper is growing demand.  It holds 47 copper mining companies worldwide, including Canada, Chile and China.  It offers a good yield that has seen the dividend grow by 30% annually over the past five years.  We recommend maintaining a stop at $68, looking to achieve $97 — upside potential of 18%.  Yield 2.3%

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate PDBC, known as the world's most diversified commodity fund that holds futures in energy, agriculture and metals as a TOP PICK.  The risk of rising inflation historically leads to dramatic increases in these commodity classes.  We recommend trailing up the stop (from $14.00) to $16.50, looking to achieve $22 -- upside potential over 18%.  Yield 0%

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate DBB as a TOP PICK.  The ETF holds a portfolio of base metal based futures contracts for aluminum, zinc and copper -- commodities expected to surge with rising inflation.  We continue to recommend maintaining a stop at $22, looking to achieve $31 -- upside potential over 18%.  Yield 0%

premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

In the last quarter, the company reported 1.87 USD per share, beating the 1.75 USD estimate by 6.52%. Revenue for the same period reached 81.61 B USD, despite the estimate of 78.91 B USD. For the next quarter, analysts expect 2.03 USD in earnings per share and 90.21 B USD in revenue. Social media mentions are up 126% in the past 24h.

premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

In the last quarter, the company reported -0.07 USD per share, beating the -0.07 USD estimate by -4.35%. Revenue for the same period reached 200.35 M USD, despite the estimate of 189.65 M USD. For the next quarter, analysts expect -0.06 USD in earnings per share and 229.72 M USD in revenue. Social media mentions are up 269% in the past 24h.

premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

In the last quarter, the company reported 12.80 USD per share, beating the 12.57 USD estimate by 1.83%. Revenue for the same period reached 8.56 B USD, despite the estimate of 8.54 B USD. For the next quarter, analysts expect 3.39 USD in earnings per share and 4.23 B USD in revenue. Social media mentions are up 650% in the past 24h.

COMMENT
Fundamentals carry more weight than geopolitics.

People react to what's going on in their own environment. We hear daily about turmoil in Iran and the Fed raising/dropping rates. What's most impactful to stock prices are the fundamentals of individual companies. 

An old adage is that "stock prices are the slaves of earnings". If a company performs well, it will manage to navigate through the external noise.

COMMENT
Beware concentration in hyperscalers and chip companies.

The risk is that we see what's working, and over time our portfolios become concentrated in those industries and sectors. The concentration introduces a lot of portfolio risk, which is only evident after it's too late.

Remember to diversify. It's not bad to have some sectors/industries that may not be rewarded today, but whose companies are great quality and will be rewarded tomorrow. Just let them stay in the shade and they will eventually appear.

For example, healthcare is at a 20-year low on market cap as a percentage of the S&P 500. Years ago, who'd have thought? Especially given the aging population and new technology in treatments. It will eventually have its time in the sun.

COMMENT
How to diversify away from AI and tech.

Healthcare is one place to look, and there are good opportunities there. It's a broad area, so you have to be careful about the sector/industry and individual company you invest in.

If you do your research and concentrate on quality companies, they'll see you through.

DON'T BUY
Investor bought last year and is down.

Tough investment over the past year. His research showed that organic growth at risk especially given its demanding multiple. Last quarter projected 6.5-8% organic growth, instead of 10-11%.

There will be a time for this stock going forward, but it's still losing market share to MDT, ABT, and JNJ.

He doesn't know the investor's specific situation, so he's reluctant to give particular advice. However, usually when an investment goes bad it's better to cut bait and move on. It's often better to put the sale proceeds to work in a more constructive idea.

HOLD

Likes the group longer term, but homebuilders have had a tough time with higher interest rates. The House passed a bill yesterday to restrict institutional ownership of homes, which should provide some support.

Likes this company, but sold on tax implications of company reorganization. Seeing some bottoming in the sector, so he'd keep holding.

HOLD

Report the other day was fairly constructive.

HOLD

Fairly constructive last report.

BUY

Long runway with Hanes acquisition. Known for its good management. Owns this in his firm's Canadian portfolio.

Most popular stocks on Stockchase